Therapeutic propensity of ginsenosides Rg1 and Rg3 in rhabdomyolysis-induced acute kidney injury and renohepatic crosstalk in rats
- 27 December 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 115, 109602
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failureFree Radical Biology and Medicine, 2011
- Chemistry and biology of reactive oxygen species in signaling or stress responsesNature Chemical Biology, 2011
- Metabolic Syndrome and Renal InjuryCardiology Research and Practice, 2011
- Cytokines induce small intestine and liver injury after renal ischemia or nephrectomyLaboratory Investigation, 2010
- The innate immune response in ischemic acute kidney injuryClinical Immunology, 2009
- The risk of acute renal failure in patients with chronic kidney diseaseKidney International, 2008
- Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosidesChinese Medicine, 2007
- Endogenous Reactive Intermediates as Modulators of Cell Signaling and Cell DeathChemical Research in Toxicology, 2006
- Proximal tubular cytochrome c efflux: Determinant, and potential marker, of mitochondrial injuryKidney International, 2004
- Myoglobin toxicity in proximal human kidney cells: Roles of Fe, Ca2+, H2O2, and terminal mitochondrial electron transportKidney International, 1997